Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics. - Wikidata - wikimedia - TriplyDB

Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.

Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.

http://www.wikidata.org/entity/Q37387518

about

Cellular immunotherapy for pediatric solid tumors A high throughput microelectroporation device to introduce a chimeric antigen receptor to redirect the specificity of human T cells.New aspects of neuroblastoma treatment: ASPHO 2011 symposium review A Phase I Study of the Anti-Idiotype Vaccine Racotumomab in Neuroblastoma and Other Pediatric Refractory Malignancies.Neuroblastoma: developmental biology, cancer genomics and immunotherapy.Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma Prospective of colon cancer treatments and scope for combinatorial approach to enhanced cancer cell apoptosis Mature dendritic cells cause Th17/Treg imbalance by secreting TGF-β1 and IL-6 in the pathogenesis of experimental autoimmune encephalomyelitis.Phase I trial of a bivalent gangliosides vaccine in combination with β-glucan for high-risk neuroblastoma in second or later remission.

P2860

Q27014912-728308B1-997A-4C90-850A-50D9840BEF87 Q30584839-16E61747-1D15-440A-854B-39DF0A45620C Q33922797-FA814C42-66A6-4ED2-A50A-CBFC8BBA8317 Q34484061-24AC32E6-A6BB-4D69-95CF-3183744CFE27 Q35283020-BC151117-B049-4AE4-B04D-68F2ECAAAB52 Q35604043-7DCAB06D-C7FF-436D-A9CF-BD28DA3EE07E Q36579336-C7EA536D-AABC-4244-BD92-5E49121A238F Q37140600-C323268F-7A8F-4ADD-ADEF-951FB7F296A3 Q41394300-B0B61AA4-CE3B-4AC0-A5C9-46A5922CDAB6

P2860

Cellular immunotherapy for neuroblastoma: a review of current vaccine and adoptive T cell therapeutics.

http://www.wikidata.org/entity/Q37387518

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@en

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@nl

type

label

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@en

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@nl

prefLabel

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@en

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@nl

P1433

Q37387518-284AA685-6C36-4200-ACF8-6AAB5977B796

P1476

Q37387518-526F5449-4BA2-40E0-A8B4-7C3A853BE7AA

P2093

Q37387518-70BA9B75-533F-48DF-85B7-43DB50E0E797

Q37387518-883B0238-9429-4A22-AE58-218262D83FF4

P2860

Q37387518-00486814-6D19-4A9F-B0B0-BE70AB342412

Q37387518-04A6FBA9-5F67-41C1-8E51-B7E4E7019F06

Q37387518-0B31F7DB-205E-4A39-B327-EE68909A1AF7

Q37387518-0EFED46D-9CF5-4F6B-AB3B-0150A1BDB985

Q37387518-1782E298-3A5B-4EC6-9EC4-A104C93775DA

Q37387518-1885F83F-CEFC-4A9E-82D5-2F19DC3764F6

Q37387518-1A9F9157-C541-466A-8CC4-A108CCDE72E8

Q37387518-24DA8532-6016-4EC9-857B-3431B999DDDE

Q37387518-251F854E-EC69-4475-9DD3-29D0673D9E3B

Q37387518-256CF174-201B-47EA-8B86-80B7C0904354

P304

Q37387518-7E6EFEB6-C92B-46BD-A4BE-D0BA20A9A106

P31

Q37387518-90596A58-82C0-4387-ACD7-3419C5057BA2

P356

Q37387518-90A68C99-D44E-472E-BF52-F700818E69C4

P433

Q37387518-16858D97-29A9-4C4A-A236-921921C5C405

P478

Q37387518-026A6E52-CF3C-49AB-95CF-2D306275036E

P577

Q37387518-22CD371F-4BE3-4E87-8EBD-FA247DD14783

P698

Q37387518-9D86AF9E-418D-4C68-9D6C-40E689440C17

P921

Q37387518-A23E315A-F7B9-4998-BDA5-BA2E250402E6

P932

Q37387518-AEF9CE31-4A56-4F4C-B885-AED5A0A5B263

P356

138161209787315765

P1433

Current Pharmaceutical Design

P1476

Cellular immunotherapy for neu ...... adoptive T cell therapeutics.

@en

P2093

C U Louis

http://www.w3.org/2001/XMLSchema#string

M K Brenner

http://www.w3.org/2001/XMLSchema#string

P2860

Lymphotactin: a cytokine that represents a new class of chemokine

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group.

HLA class I antigen abnormalities and immune escape by malignant cells.

Antibody-based immunotherapy in high-risk neuroblastoma.

Targeting tumours with genetically enhanced T lymphocytes.

Tumour escape: antitumour effectors too much of a good thing?

Cellular cytotoxicity mediated by isotype-switch variants of a monoclonal antibody to human neuroblastoma.

Immunogenicity of human neuroblastoma.

P304

424-429

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2174/138161209787315765

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P577

2009-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19199969

http://www.w3.org/2001/XMLSchema#string

P921

P932

4122212

http://www.w3.org/2001/XMLSchema#string